World Celiac Disease Pipeline Insight Report 2018: Developmental Stage, Associated Indications, Route of Administration and Molecule Type - ResearchAndMarkets.com

DUBLIN--()--The "Celiac Disease - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'Celiac Disease - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Celiac Disease development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

The report assesses the active Celiac Disease pipeline products by developmental stage, product type, molecule type, and administration route.

Key Topics Covered:

1. Report Introduction

2. Celiac Disease Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Celiac Disease

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Mentioned

  • Amgen Inc
  • Amyra Biotech AG
  • Calypso Biotech SA
  • Circle33 LLC
  • F. Hoffmann-La Roche Ltd
  • Glenmark Pharmaceuticals Ltd
  • ImmusanT Inc
  • Innovate Biopharmaceuticals Inc
  • Intrexon Corp
  • Sanofi
  • Takeda Pharmaceutical Company Ltd

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/6jxcsw/world_celiac?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Gastrointestinal Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Gastrointestinal Drugs